bimagrumab glp-1 A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for 𝗕𝗶𝗺𝗮𝗴𝗿𝘂𝗺𝗮𝗯: 𝗣𝗿𝗲𝘀𝗲𝗿𝘃𝗶𝗻𝗴 𝗠𝘂𝘀𝗰𝗹𝗲 𝗠𝗮𝘀𝘀 𝗗𝘂𝗿𝗶𝗻𝗴

Learn how SGLT2 inhibitors interact with weight loss surgery in patients with diabetes

Carolyn Dean MD ND.

Eli Lilly CEO David Ricks announces details of the Medicare GLP-1 bridge program, offering weight loss medications like Fondeo and Zepbound for $50 per month to 20 million eligible Medicare Part D patients starting July 1.

With GLP-1 usage, the biggest change to restaurants wont be that consumers stop going out to eat, it will be how they go out to eat and what they order.

Oprah Winfrey says the disappearance of so-called food noise is one of the most amazing effects of her GLP-1 drug

High-fidelity Reta for triple receptor signaling studies.